OptraSCAN Digital Pathology Launches Fluorescent Whole Slide Imaging Scanner at MMTC 2017, as Part of its On-Demand Model

Fluorescent whole slide imaging for pathologists, neuroscientists and cellular biologists

Consulting CMO Dr. Clive Taylor unveiling the new 'OS-FL' Fluorescent OptraSCAN Scanner (Photo: Business Wire)

???pagination.previous??? ???pagination.next???

SUNNYVALE, Calif.--()--OptraSCAN announces today it has launched a Fluorescent Whole Slide Imaging scanner for fluorescence microscopy at Molecular Med Tri Conference (MMTC) in San Francisco, as part of its On-Demand Subscription model for molecular pathologists, neuroscientists and cell biologists.

OptraSCAN is exhibiting its new Fluorescent scanner (OS-FL) at this week’s MMTC, booth #115, and will be holding a workshop, “Cost-effective Fluorescent and Brightfield Scanning in the Cloud,” Tuesday, 2/21, at 3:40 p.m. in the Digital Pathology track, presented by consulting Chief Medical Officer Dr. Clive Taylor.

The small footprint OS-FL Fluorescent WSI scanner provides digital scanning of fluorescence slides to traditional microscopy users. The OS-FL scanner is equipped with five filter cubes and supports both fluorescent and brightfield scanning. The scanner offers 15 or 120-slide scanning capacity, a 20X and 40X objective lens, cloud-enabled image management and 10 TB of cloud storage.

Users can access OptraSCAN’s On-Demand model offering an affordable monthly rate with no upfront costs, or an outright purchase. The OS-FL scanner includes the cloud-enabled ImagePath™ image viewing and management system and telepathology TELEPath™; and is also compatible with optional On-Demand image analysis OptraASSAYS™ and CARDS™, and CLOUDPath™ cloud-enabled LIMS through Salesforce’s Health Cloud offering.

“The global fluorescence microscopy market value is projected to be at over $500M by 2018,” says OptraSCAN founder and CEO Abhi Gholap. “Demand will continue to grow at over 10% annually due to the steady stream of new instrumentation being developed. The applications of fluorescent imaging are centered on biological research, and include neuroscience and cell biology.”

OptraSCAN was also recently chosen by the National Institute of Neurological Disorders and Stroke (NINDS), NIH to provide a confocal and widefield fluorescence scanner with high-speed, high-throughput, high-capacity and high-content digital imaging, that seamlessly integrates with image acquisition, image processing and quantitative image analysis software.

About OptraSCAN, Inc.

OptraSCAN (www.optrascan.com) for research-use-only, is the first On-Demand Digital Pathology system to provide a comprehensive, affordable end-to-end Digital Pathology solution for both low-volume and high-throughput users. OptraSCAN™ serves as a perfect tool for the transition from conventional microscopy to Digital Pathology for the effective acquisition of Whole Slide images, viewing, sharing, analysis and management of digital slides and associated metadata. Focused on delivering fully integrated Digital Pathology solutions that maximize quality, efficiency and throughput of its customers’ pathology labs (at minimized cost), paired with a complementary Whole Slide image scanner and viewer—Optra Systems facilitates a complete Whole Slide Image solution system via an on-demand pay-per-use program. Follow OptraSCAN on Linkedin and Twitter.

Contacts

OptraSCAN, Inc.
Media Inquiries:
Jennifer Levy
408-524-5300 x104
Jennifer@optrainc.com
or
Sales Inquiries:
Mike Oria
408-524-5300
Mike@optrascan.com

Release Summary

OptraSCAN has launched a Fluorescent Whole Slide Imaging scanner for fluorescence microscopy for molecular pathologists, neuroscientists and cellular biologists.

Contacts

OptraSCAN, Inc.
Media Inquiries:
Jennifer Levy
408-524-5300 x104
Jennifer@optrainc.com
or
Sales Inquiries:
Mike Oria
408-524-5300
Mike@optrascan.com